
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $63.1M | $75.2M | $84.2M | $97.4M | $84.6M | |
Revenue Growth (YoY) | -7.28% | 19.18% | 11.96% | 15.77% | -13.14% | |
Cost of Revenues | $40.5M | $49.7M | $58M | $67.7M | $54.3M | |
Gross Profit | $22.6M | $25.5M | $26.2M | $29.8M | $30.3M | |
Gross Profit Margin | 35.84% | 33.91% | 31.07% | 30.55% | 35.79% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $5.5M | $2.6M | -$53.6M | $2.7M | $4.9M | |
Operating Expenses | $10.1M | $10.7M | $11.2M | $12.1M | $13.2M | |
Operating Income | $12.5M | $14.8M | $14.9M | $17.7M | $17.1M | |
Net Interest Expenses | $4.1M | $4.1M | $4.5M | $5.6M | $6.5M | |
EBT. Incl. Unusual Items | $13.9M | $13.3M | -$43.1M | $14.8M | $15.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3.3M | $3.2M | -$11.4M | $3.5M | $3.7M | |
Net Income to Company | $10.6M | $10.1M | -$31.7M | $11.3M | $11.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $10.6M | $10.1M | -$31.7M | $11.3M | $11.8M | |
Basic EPS (Cont. Ops) | $1.30 | $1.22 | -$3.48 | $1.14 | $1.16 | |
Diluted EPS (Cont. Ops) | $1.30 | $1.22 | -$3.48 | $1.14 | $1.16 | |
Weighted Average Basic Share | $8.1M | $8.3M | $9.1M | $9.9M | $10.2M | |
Weighted Average Diluted Share | $8.1M | $8.3M | $9.1M | $9.9M | $10.2M | |
EBITDA | $26.1M | $26M | -$29.5M | $30.4M | $32.5M | |
EBIT | $18M | $17.4M | -$38.6M | $20.4M | $22M | |
Revenue (Reported) | $63.1M | $75.2M | $84.2M | $97.4M | $84.6M | |
Operating Income (Reported) | $12.5M | $14.8M | $14.9M | $17.7M | $17.1M | |
Operating Income (Adjusted) | $18M | $17.4M | -$38.6M | $20.4M | $22M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $28.3M | $29.5M | $38M | $32.7M | $36.5M | |
Revenue Growth (YoY) | 25.92% | 4.52% | 28.79% | -14.12% | 11.64% | |
Cost of Revenues | $18.4M | $19.2M | $25.4M | $20.6M | $22.4M | |
Gross Profit | $9.9M | $10.4M | $12.6M | $12M | $14.1M | |
Gross Profit Margin | 34.94% | 35.08% | 33.26% | 36.84% | 38.59% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $283.8K | -$39.5M | $124.7K | $1.3M | $1.3M | |
Operating Expenses | $2.8M | $2.9M | $3.1M | $3.4M | $3.7M | |
Operating Income | $7.1M | $7.4M | $9.6M | $8.6M | $10.4M | |
Net Interest Expenses | $1M | $1.1M | $1.4M | $1.6M | $1.6M | |
EBT. Incl. Unusual Items | $6.4M | -$33.1M | $8.3M | $8.4M | $10M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.6M | -$8.6M | $2M | $1.9M | $2.4M | |
Net Income to Company | $4.8M | -$24.5M | $6.3M | $6.4M | $7.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $4.8M | -$24.5M | $6.3M | $6.4M | $7.7M | |
Basic EPS (Cont. Ops) | $0.58 | -$2.89 | $0.64 | $0.63 | $0.74 | |
Diluted EPS (Cont. Ops) | $0.58 | -$2.89 | $0.64 | $0.63 | $0.74 | |
Weighted Average Basic Share | $8.2M | $8.5M | $9.9M | $10.2M | $10.3M | |
Weighted Average Diluted Share | $8.2M | $8.5M | $9.9M | $10.2M | $10.3M | |
EBITDA | $9.6M | -$29.7M | $12.2M | $12.7M | $14.5M | |
EBIT | $7.4M | -$32M | $9.7M | $9.9M | $11.7M | |
Revenue (Reported) | $28.3M | $29.5M | $38M | $32.7M | $36.5M | |
Operating Income (Reported) | $7.1M | $7.4M | $9.6M | $8.6M | $10.4M | |
Operating Income (Adjusted) | $7.4M | -$32M | $9.7M | $9.9M | $11.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $68.6M | $80.2M | $102.7M | $83.2M | $91.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $45M | $54.3M | $73.9M | $52.6M | $58.1M | |
Gross Profit | $23.6M | $25.9M | $28.7M | $30.6M | $33.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $4.7M | -$38.5M | -$14.3M | $5.4M | $4.6M | |
Operating Expenses | $10.5M | $11M | $11.5M | $12.8M | $13.7M | |
Operating Income | $13.1M | $14.9M | $17.2M | $17.8M | $19.5M | |
Net Interest Expenses | $4M | $4.2M | $5.1M | $6.1M | $6.7M | |
EBT. Incl. Unusual Items | $13.8M | -$27.8M | -$2.1M | $17.2M | $17.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3.4M | -$7.5M | -$877K | $4M | $4.1M | |
Net Income to Company | $10.4M | -$20.3M | -$1.2M | $13.2M | $13.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $10.4M | -$20.3M | -$1.2M | $13.2M | $13.2M | |
Basic EPS (Cont. Ops) | $1.27 | -$2.39 | -$0.13 | $1.30 | $1.28 | |
Diluted EPS (Cont. Ops) | $1.27 | -$2.39 | -$0.13 | $1.30 | $1.28 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $26.2M | -$14.6M | $12.4M | $33.8M | $35M | |
EBIT | $17.8M | -$23.6M | $3M | $23.3M | $24.1M | |
Revenue (Reported) | $68.6M | $80.2M | $102.7M | $83.2M | $91.3M | |
Operating Income (Reported) | $13.1M | $14.9M | $17.2M | $17.8M | $19.5M | |
Operating Income (Adjusted) | $17.8M | -$23.6M | $3M | $23.3M | $24.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $47.8M | $52.8M | $71.3M | $57.1M | $63.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $29.6M | $34.2M | $50.1M | $35.1M | $38.8M | |
Gross Profit | $18.2M | $18.6M | $21.2M | $22M | $25M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $2M | -$39.1M | $200.5K | $2.9M | $2.6M | |
Operating Expenses | $5.5M | $5.8M | $6.1M | $6.7M | $7.2M | |
Operating Income | $12.7M | $12.8M | $15.1M | $15.3M | $17.7M | |
Net Interest Expenses | $2M | $2.2M | $2.8M | $3.2M | $3.4M | |
EBT. Incl. Unusual Items | $12.6M | -$28.5M | $12.6M | $15M | $16.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3.1M | -$7.6M | $3M | $3.5M | $4M | |
Net Income to Company | $9.5M | -$20.9M | $9.6M | $11.5M | $12.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $9.5M | -$20.9M | $9.6M | $11.5M | $12.9M | |
Basic EPS (Cont. Ops) | $1.16 | -$2.46 | $0.97 | $1.13 | $1.25 | |
Diluted EPS (Cont. Ops) | $1.16 | -$2.46 | $0.97 | $1.13 | $1.25 | |
Weighted Average Basic Share | $16.4M | $16.9M | $19.7M | $20.2M | $20.6M | |
Weighted Average Diluted Share | $16.4M | $16.9M | $19.8M | $20.2M | $20.6M | |
EBITDA | $19.1M | -$21.6M | $20.3M | $23.7M | $26M | |
EBIT | $14.7M | -$26.3M | $15.3M | $18.2M | $20.3M | |
Revenue (Reported) | $47.8M | $52.8M | $71.3M | $57.1M | $63.8M | |
Operating Income (Reported) | $12.7M | $12.8M | $15.1M | $15.3M | $17.7M | |
Operating Income (Adjusted) | $14.7M | -$26.3M | $15.3M | $18.2M | $20.3M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $291.1K | $1.5M | $4.9M | $1.5M | $894.2K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $3.4M | $4.9M | $5.4M | $4.2M | $4.5M | |
Inventory | $6.7M | $8.9M | $18.1M | $12.9M | $10.3M | |
Prepaid Expenses | $647.6K | $3.1M | $3.1M | $3.2M | $2.4M | |
Other Current Assets | $3.4M | $6.7M | $2.8M | $3.5M | $6.2M | |
Total Current Assets | $14.4M | $25.1M | $35.5M | $26.8M | $25.1M | |
Property Plant And Equipment | $198.4M | $211.6M | $229.9M | $247.6M | $262M | |
Long-Term Investments | $57.5M | $64.9M | $13.8M | $17.2M | $21.1M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $285K | $418.9K | $293.6K | $624.1K | $703.4K | |
Total Assets | $281.7M | $310.1M | $290.3M | $303.7M | $320.7M | |
Accounts Payable | $4.4M | $7.7M | $8.6M | $5.8M | $5.4M | |
Accrued Expenses | $3.6M | $3.8M | $3.7M | $4.7M | $5M | |
Current Portion Of Long-Term Debt | -- | $7M | $1.3M | $11M | $800K | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $1.4M | $662.4K | $3.2M | $1.7M | $860K | |
Total Current Liabilities | $16.6M | $26M | $22.3M | $32.9M | $28.7M | |
Long-Term Debt | $123.8M | $133.5M | $135.7M | $125.8M | $136.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $192.8M | $210.4M | $197.2M | $203M | $212.6M | |
Common Stock | $40.8M | $41.9M | $49.1M | $50.1M | $51.2M | |
Other Common Equity Adj | -$3.4M | -$1.5M | $2M | $2.3M | $1.3M | |
Common Equity | $88.9M | $99.7M | $93.1M | $100.7M | $108.1M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $88.9M | $99.7M | $93.1M | $100.7M | $108.1M | |
Total Liabilities and Equity | $281.7M | $310.1M | $290.3M | $303.7M | $320.7M | |
Cash and Short Terms | $291.1K | $1.5M | $4.9M | $1.5M | $894.2K | |
Total Debt | $123.8M | $140.5M | $137M | $141.2M | $148.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $726.6K | $9.4M | $6.6M | $2M | $2.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $9.8M | $11M | $10.1M | $9.5M | $13.6M | |
Inventory | $2.4M | $3.1M | $6.3M | $6.7M | $3.9M | |
Prepaid Expenses | -- | $2.1M | $3.1M | $1.8M | $524.2K | |
Other Current Assets | $3.6M | $6.6M | $5M | $7.3M | $4.6M | |
Total Current Assets | $16.6M | $32.5M | $32.4M | $28.5M | $25.8M | |
Property Plant And Equipment | $203.7M | $218.7M | $239.3M | $254.1M | $267.6M | |
Long-Term Investments | $60.5M | $27.3M | $15.1M | $19.9M | $21M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $383.3K | $371.5K | $258.2K | $571K | $660.5K | |
Total Assets | $292.2M | $288.4M | $296.5M | $313.4M | $326.4M | |
Accounts Payable | $4.6M | $5.8M | $7.2M | $5.4M | $6M | |
Accrued Expenses | $2.7M | $2.8M | $3M | $3.2M | $3.4M | |
Current Portion Of Long-Term Debt | $7M | $19.7M | $25.1M | $125K | $26.6M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | $31K | -- | |
Other Current Liabilities | $578.8K | $3.2M | $3.4M | $2.6M | $4.7M | |
Total Current Liabilities | $20.8M | $36.6M | $43.6M | $21.7M | $45.5M | |
Long-Term Debt | $120.8M | $104.8M | $112.8M | $135.9M | $115.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $194.6M | $182.9M | $196.2M | $202.8M | $208.6M | |
Common Stock | $41.1M | $48.9M | $49.6M | $50.9M | $51.5M | |
Other Common Equity Adj | -$2.8M | $340K | $1.3M | $1.5M | $1.2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $97.6M | $105.5M | $100.3M | $110.5M | $117.8M | |
Total Liabilities and Equity | $292.2M | $288.4M | $296.5M | $313.4M | $326.4M | |
Cash and Short Terms | $726.6K | $9.4M | $6.6M | $2M | $2.2M | |
Total Debt | $127.8M | $124.5M | $137.9M | $142.6M | $141.8M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $10.6M | $10.1M | -$31.7M | $11.3M | $11.8M | |
Depreciation & Amoritzation | $8.1M | $8.7M | $9.2M | $10M | $10.5M | |
Stock-Based Compensation | $81.4K | $11.1K | $16.3K | $21.6K | $711.9K | |
Change in Accounts Receivable | $53.2K | -$1.1M | -$646.4K | $1.4M | -$275.2K | |
Change in Inventories | $734.2K | -$2.2M | -$9.2M | $5.3M | $2.6M | |
Cash From Operations | $12.8M | $11.6M | $15.6M | $23.8M | $17.4M | |
Capital Expenditures | $22.9M | $20M | $25.5M | $25.3M | $22.1M | |
Cash Acquisitions | -$7.9M | -$6M | -$5.3M | -$2.1M | -$18.3K | |
Cash From Investing | -$30.7M | -$25.8M | -$30.6M | -$27.4M | -$22M | |
Dividends Paid (Ex Special Dividend) | -$5.6M | -$6M | -$7M | -$7.8M | -$8.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $43.8M | $55.2M | $76.2M | $34.3M | $56.2M | |
Long-Term Debt Repaid | -$23.4M | -$38.6M | -$79.6M | -$30.1M | -$48.8M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$70.8K | -$21.6K | -$58.2K | -$33.7K | -$101.2K | |
Cash From Financing | $16.6M | $15.5M | $18.4M | $218.9K | $4M | |
Beginning Cash (CF) | $1.6M | $291.1K | $1.5M | $4.9M | $1.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$1.3M | $1.2M | $3.4M | -$3.4M | -$618.3K | |
Ending Cash (CF) | $291.1K | $1.5M | $4.9M | $1.5M | $894.2K | |
Levered Free Cash Flow | -$10.1M | -$8.4M | -$9.9M | -$1.5M | -$4.7M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $610.8K | $592.5K | $686.8K | $156.7K | -- | |
Depreciation & Amoritzation | $2.2M | $2.3M | $2.5M | $2.8M | -- | |
Stock-Based Compensation | $2.8K | -- | -- | -$418.6K | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $4.8M | $6.8M | $6.7M | $5.9M | -- | |
Capital Expenditures | $6M | $6.7M | $6.5M | $5.3M | -- | |
Cash Acquisitions | -$1.5M | -$773.7K | -$633.3K | -$5.4K | -- | |
Cash From Investing | -$7.3M | -$7.4M | -$7.1M | -$5.3M | -- | |
Dividends Paid (Ex Special Dividend) | -$1.5M | -$1.9M | -$2M | -$2M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $13.7M | $6.6M | $1.8M | $18.6M | -- | |
Long-Term Debt Repaid | -$11.4M | -- | -$2.3M | -$16.9M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$12K | $3.1K | -$66.1K | -- | |
Cash From Financing | $3M | $5M | -$1000K | -$68.8K | -- | |
Beginning Cash (CF) | $726.6K | $9.4M | $6.6M | $2M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $541.9K | $4.4M | -$1.4M | $521.9K | -- | |
Ending Cash (CF) | $1.3M | $13.8M | $5.2M | $2.5M | -- | |
Levered Free Cash Flow | -$1.2M | $131.9K | $151.8K | $564.7K | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $10.4M | -$20.3M | -$1.2M | $13.2M | $13.2M | |
Depreciation & Amoritzation | $8.4M | $8.9M | $9.5M | $10.6M | $10.7M | |
Stock-Based Compensation | $81.4K | $16.7K | $32.3K | $470.1K | $689.4K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $11.3M | $14.9M | $19.5M | $18M | $28.1M | |
Capital Expenditures | $21.5M | $21.7M | $27.6M | $23.7M | $21.5M | |
Cash Acquisitions | -$4.7M | -$6.9M | -$3.2M | -$637.6K | -$50K | |
Cash From Investing | -$26.1M | -$28.4M | -$30.7M | -$24.3M | -$21.5M | |
Dividends Paid (Ex Special Dividend) | -$5.8M | -$6.3M | -$7.7M | -$7.9M | -$8.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $43.3M | $90M | $41.3M | $34.2M | $57.7M | |
Long-Term Debt Repaid | -$27.8M | -$93.2M | -$28M | -$29.4M | -$58.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $11.7M | $22.2M | $8.4M | $1.7M | -$6.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$3.1M | $8.7M | -$2.8M | -$4.6M | $133.6K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$10.2M | -$6.8M | -$8M | -$5.7M | $6.6M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $10.1M | -$20.3M | $10.3M | $11.6M | $12.9M | |
Depreciation & Amoritzation | $6.6M | $6.9M | $7.4M | $8.3M | $5.7M | |
Stock-Based Compensation | $2.8K | $5.6K | $21.6K | $51.5K | $447.6K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $14.4M | $19.8M | $23.6M | $17.1M | $21.8M | |
Capital Expenditures | $15M | $17.4M | $19.4M | $16.6M | $10.7M | |
Cash Acquisitions | -$4.2M | -$4.3M | -$2.1M | -$8.7K | -$35.2K | |
Cash From Investing | -$19M | -$21.7M | -$21.5M | -$16.5M | -$10.7M | |
Dividends Paid (Ex Special Dividend) | -$4.5M | -$5.1M | -$5.8M | -$6M | -$4.2M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $40M | $67.8M | $28.1M | $44.7M | $27.6M | |
Long-Term Debt Repaid | -$33.8M | -$77.1M | -$27.7M | -$41.5M | -$34.4M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$51.7K | -$10.8K | -$99.4K | -$2K | |
Cash From Financing | $5.6M | $14.2M | -$1.9M | $516.7K | -$9.9M | |
Beginning Cash (CF) | $1.8M | $12.7M | $14.8M | $6.4M | $3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $977.3K | $12.3M | $282.2K | $1M | $1.3M | |
Ending Cash (CF) | $2.7M | $25M | $15M | $7.4M | $4.3M | |
Levered Free Cash Flow | -$546.2K | $2.4M | $4.3M | $487.6K | $11.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.